Population
273 men divided into 7 groups: 72 with normolipidemia and clinical CHD, 34 NLP with angiographic CAD, 37…
Design
Cross-sectional
Authors
Loading...
LDL-apoB should not supplant LDL-C for normolipidemic CHD risk assessment; leaves open enhanced utility in hypertriglyceridemia.
LDL-apoB may not be a better indicator of coronary risk than LDL-C in normolipidemic individuals, but it could be a superior predictor of risk in patients with hypertriglyceridemia.
Vega et al. (1984) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: